Facebook Users

Will BSGLF go up?

BSGLF Biosignal Ltd featured news, full reports, and detailed charts

Biosignal Ltd (BSGLF/BSGLF.PK) Wrap Up:

Biosignal Limited engages in the research and development of anti-biofilm technology-based products in Australia. The company?s anti-biofilm compounds reduce bacteria's ability to form biofilms on surfaces, including contact lenses, medical devices, and oil and gas pipelines, as well as membranes animate surfaces, such as lungs, skin, and teeth. Its products are used as drug candidates for the treatment of lung infections, as well as in various applications, such as oil and gas, marine anti-fouling paints, water treatment, oral care products, cleaners, deodorants, contact lenses and contact lens solutions, and catheters. The company was founded in 1999 and is based in Eveleigh, Australia.
www.biosignal.com.au
Founded in 1999

Biosignal Ltd (BSGLF:Pink OTC Markets Inc)

LAST $0.0050 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of July 10, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).

Snapshot of Biosignal Ltd (BSGLF)

OPEN
--
PREVIOUS CLOSE
$0.0050
DAY HIGH
--
DAY LOW
--
52 WEEK HIGH
05/13/09 - $0.02
52 WEEK LOW
03/10/09 - $0.0010
MARKET CAP
652.1K
AVERAGE VOLUME 3 mo
0.0
DILUTED EPS TTM
--
SHARES OUTSTANDING
130.4M
BSGLF Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

BSGLF Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

Key developments for Biosignal Ltd (BSGLF)

Biosignal Ltd. Announces Consolidated and Parent Earnings Results for the Year Ended June 30, 2009

Biosignal Ltd. announced consolidated and parent earnings results for the year ended June 30, 2009. For the year, the company reported consolidated loss of AUD 3,881,881 or 3.3 cents per diluted share on revenue of AUD 125,246 compared to consolidated loss of AUD 4,398,934 or 4.2 cents per diluted share on revenue of AUD 928,080 for the same period a year ago. Loss before income tax was AUD 3,881,881 compared to AUD 4,398,934 for the same period a year ago. Net cash flows used in operating activities was AUD 1,464,295 compared to AUD 2,921,448 for the same period a year ago. For the year, the company reported parent loss of AUD 1,395,180 on revenue of AUD 125,246 compared to loss of AUD 3,180,935 on revenue of AUD 928,080 for the same period a year ago. Loss before income tax was AUD 1,395,180 compared to AUD 3,180,935 for the same period a year ago. Net cash flows used in operating activities was AUD 1,464,295 compared to AUD 2,921,448 for the same period a year ago.

Biosignal Ltd., Annual General Meeting, Dec 16, 2009

Biosignal Ltd., Annual General Meeting, Dec 16, 2009, at 11:00 EAST-East Australian Standard GST. Location: Middletons, Level 25 South Tower, The Rialto, 525 Collins Street, Melbourne, VIC 3000, Australia.

Biosignal Ltd. Reports Consolidated and Standalone Earnings Results for the Year Ended June 30, 2009

Biosignal Ltd. reported consolidated and standalone earnings results for the year ended June 30, 2009. For the year, on consolidated basis, the company reported revenue of AUD 125,246 compared to revenue of AUD 928,080 for the same period last year. Loss before tax and loss after tax was AUD 3,875,753 or AUD 3.3 basic per share compared to loss before tax and loss after tax of AUD 4,398,934 or AUD 4.2 for the same period last year. Net cash used in operating activities was AUD 1,463,896 compared to AUD 2,921,448 for the same period of last year. For the year, on standalone basis, the company reported revenue of AUD 15,400 compared to revenue of AUD 250,911 for the same period last year. Loss before tax and loss after tax was AUD 1,389,052 compared to loss before tax and loss after tax of AUD 3,180,935 for the same period last year. Net cash used in operating activities was AUD 1,463,896 compared to AUD 2,921,448 for the same period of last year.

otc, otcbb, pinksheet, BSGLF, ob Biosignal Ltd

BSGLF Competitors

Company Last Change
No competitor information is available for BSGLF.
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation BSGLF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 36.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 38.3x

BSGLF

 | 

BSGLF transactions

Type
Date
Target
Merger/Acquisition
July 31, 2009
--

More Recent News About Biosignal Ltd

More news for BSGLF

Preliminary 2009 BIOSIGNAL LTD Earnings Release - After Market Close

Earnings Announcements for Monday, August 31CompanySymbolTimeConferenceCall104 CORP3130.TWTime Not SuppliedACCESS COMMERCECES.PATime Not SuppliedAIG International Real EstateARE.FTime Not SuppliedALBIS LEASING AGALG.FTime Not SuppliedAltran TechnologiesALT.PATime Not SuppliedAMTRAN TECHNOLOGY2489.TWAfter Market CloseAPRIL GROUPAPR.PAAfter Market CloseAreva CIARVCF.PKTime Not SuppliedARIMA COMMUNICATION CORP8101.TWTime Not SuppliedARIMA OPTOELECTRONICS CORP6289.TWAfter Market CloseARTPRICE.COMPRC.PATime Not SuppliedASIA CEMENT CORP1102.TWTime Not SuppliedAVOCA RESOURCES LTDAVORF.PKAfter Market CloseBANK LEUMI LE ISRAEL TEL AVIVLUMI.TATime Not SuppliedBenihana Inc.BNHNAAfter Market CloseListenBiomericaBMRA.OBTime Not SuppliedBLUE STAR NEW CHEMICAL MATERIAL CO.600299.SSTime Not Supplied...
Click here to read the whole Article (external link)

Would you like to leave a comment about Biosignal Ltd BSGLF/BSGLF.PK

Besides Biosignal Ltd there is more great information available at Realpennies.com